The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell Carcinoma
- 80 Downloads
Pulmonary peripheral-type squamous cell carcinoma (p-SqCC) has been increasing in incidence. However, little is known about the clinicopathologic features of p-SqCC. This study aimed to investigate the clinicopathologic characteristics and clinical outcomes of p-SqCC compared with central-type SqCC (c-SqCC) in a large cohort of surgically resected lung SqCC patients with long-term follow-up results.
The study included 268 patients with SqCC who underwent surgical resection at the authors’ institute from January 1990 to September 2013. The mean follow-up period was 67.1 months. The clinicopathologic and genetic characteristics were investigated in relation to their association with progression-free survival (PFS) and overall survival (OS) based on tumor location.
The study cohort included 120 patients with p-SqCC and 148 patients with c-SqCC. Compared with c-SqCC, p-SqCC was correlated with older age (p = 0.002), female sex (p = 0.033), better performance status (p < 0.001), smaller tumor (p = 0.004), less lymph node metastasis (p < 0.001), and an earlier pathologic stage (p < 0.001). Despite the clinicopathologic differences, tumor location was not significantly correlated with clinical outcomes. For the p-SqCC patients, the multivariate analysis showed a significant correlation of lymphovascular invasion (PFS, p < 0.001; OS, p < 0.001) and lymph node metastasis (p = 0.007; OS, p = 0.022) with poor PFS and OS, but a significant correlation of incomplete tumor resection (PFS, p = 0.009) only with poor PFS.
The clinicopathologic features differed between the p-SqCC and c-SqCC patients. Lymphovascular invasion and lymph node metastasis were independent prognostic factors of p-SqCC. These prognostic factors may be potentially used as indicators for adjuvant therapies to be used with patients who have p-SqCC.
The authors thank Professor Yung-Chie Lee (23 October 1948 to 30 December 2010), a pioneer and leader of thoracic surgery in Taiwan, for his substantial contribution to patient care and surgery. The authors also thank Chih-Hsin Chen for her skillful technical support and clinical data collection. This study was funded by the National Taiwan University Hospital, Taipei, Taiwan (NTUH107-N004038) and the Ministry of Science and Technology, Taiwan (105-2628-B-002-011-MY2).
There are no conflicts of interest.
- 1.American Cancer Society. Cancer Facts & Figures 2017. Atlanta: American Cancer Society; 2016. p 10.Google Scholar
- 5.Hayashi T, Sano H, Egashira R, et al. Difference of morphology and immunophenotype between central and peripheral squamous cell carcinomas of the lung. Biomed Res Int. 2013;2013:157838.Google Scholar
- 7.Mizushima Y, Yamashita R, Kusajima Y, et al. Prognostic comparison between peripheral and central types of squamous cell carcinoma of the lung in patients undergoing surgical resection. Oncol Rep. 2000;7:319–22.Google Scholar
- 11.Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of tumours of the lung, pleura, thymus, and heart. Lyon: International Agency for Research on Cancer; 2015.Google Scholar
- 12.American Joint Committee on Cancer. Lung. In: Rami-Porta R, Asamura H, Travis WD, Rusch VW (eds) AJCC cancer staging manual, 8th ed. New York: Springer; 2017. pp 431–56.Google Scholar